COMMUNIQUÉS West-GlobeNewswire
-
CORRECTION from Source -- Emblem Corp.
22/08/2018 - 14:35 -
Teladoc Health to Participate in Upcoming Investor Conference
22/08/2018 - 14:35 -
Minerva Neurosciences Announces Findings Showing Effect of Roluperidone on Brain-Derived Neurotrophic Factor (BDNF)
22/08/2018 - 14:30 -
Assure Holdings Reports that Cease Trade Order was Revoked by BCSC
22/08/2018 - 14:30 -
Harvard Bioscience Announces Management Change
22/08/2018 - 14:30 -
Tabula Rasa HealthCare Executive Receives 2018 Minority Business Leader Award
22/08/2018 - 14:30 -
Indi Molecular Appoints Dr. Michael T. Klimas as Senior VP Strategy & Technical Business Development
22/08/2018 - 14:29 -
Chiesi USA, Inc. Named a Best Place to Work
22/08/2018 - 14:00 -
BioSig Technologies to Present at the MicroCap Leadership Summit
22/08/2018 - 14:00 -
American Health Council Recognizes Kathleen Burns, DNP, APRN, ACCNS-AG, ACNS-BC, CEN as “America’s Best Nurse”
22/08/2018 - 14:00 -
BioSyent Releases Q2 and H1 2018 Results
22/08/2018 - 14:00 -
Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc.
22/08/2018 - 14:00 -
Easton Pharmaceuticals Begins Discussions to Acquire an Interest in an Operating Casino and Hotel Resort in Greece with Revenues in Excess of 60 Million Euro Per Year
22/08/2018 - 14:00 -
VIVUS to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 5, 2018
22/08/2018 - 13:30 -
Merus Announces Formation of a Scientific Advisory Board
22/08/2018 - 13:00 -
Revive Therapeutics Applies To FDA For Orphan Drug Designation of Cannabidiol For Treatment Of Liver Transplantation
22/08/2018 - 13:00 -
Resverlogix Supports Epigenetics Satellite Symposium and Provides Oral Presentation on Apabetalone at the European Society of Cardiology Congress 2018 in Munich
22/08/2018 - 13:00 -
Emblem Corp. Reports Second Quarter 2018 Financial Results
22/08/2018 - 12:30 -
Avivagen Announces Vivamune Distribution Agreement for the GTA
22/08/2018 - 12:30
Pages